Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1Classical hematology 1CNS 1Breast 1

Conditions

Melanoma 791Carcinoma, Non-Small-Cell Lung 171Skin Neoplasms 154Neoplasms 107Neoplasm Metastasis 100Colorectal Neoplasms 97Carcinoma, Renal Cell 95Uveal Melanoma 92Breast Neoplasms 89Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 84Lung Neoplasms 81Ovarian Neoplasms 79Sarcoma 67Lymphoma, T-Cell, Cutaneous 67Carcinoma, Merkel Cell 66Pancreatic Neoplasms 59Stomach Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 53Uterine Cervical Neoplasms 52Urinary Bladder Neoplasms 50Esophageal Neoplasms 44Triple Negative Breast Neoplasms 43Prostatic Neoplasms 43Endometrial Neoplasms 41Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 35

Interventions

IPI-926 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Basal Cell Nevus Syndrome × Dermatologic × 1 year × Clear all
NCT03050268 2026-04-23

SJFAMILY

St. Jude Children's Research Hospital

Recruiting
1,500 enrolled
BreastCNSClassical hematologyDermatologicEndocrineGastrointestinalGynecologicLymphoidOther solid neoplasmSarcoma

Turcot syndrome, Juvenile polyposis syndrome, Choroid Plexus Carcinoma, GATA2 Deficiency, Basal Cell Nevus Syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Fanconi Anemia, Hamartoma Syndrome, Multiple, von Hippel-Lindau Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Melanoma, Neuroblastoma, Neurofibromatosis 1, Noonan Syndrome, Pancreatic Neoplasms, Paraganglioma, Peutz-Jeghers Syndrome, Pheochromocytoma, Rothmund-Thomson Syndrome, Adenomatous Polyposis Coli, Retinoblastoma, Rhabdomyosarcoma, Tuberous Sclerosis, Neurofibromatosis 2, Li-Fraumeni Syndrome, Adrenocortical Carcinoma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Dyskeratosis Congenita, Genetic Predisposition to Disease, Anemia, Diamond-Blackfan, Carney Complex, Hereditary Breast and Ovarian Cancer Syndrome

NCT06050122 2025-10-14

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Sol-Gel Technologies, Ltd.

Phase 3 Active not recruiting
140 enrolled
Dermatologic

Basal Cell Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡